Onercept
Onercept is a recombinant soluble human tumor necrosis factor-alpha p55 receptor for use in Crohn's disease research[1].
Product Specifications
CAS Number
199685-57-9
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/onercept.html
Solubility
10 mM in DMSO
Smiles
[Onercept]
References & Citations
[1]Paul Rutgeerts, et al. Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006 Jul;4 (7) :888-93.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog